Viatris Inc. VTRS
18.92 USD +0.25 (+1.34%)
At closeNov 3, 2026, 4:09 PM EST
18.92 0.00 0.00%
After hours · Nov 3, 4:09 PM ET
18.64 Day range 18.94
9.92 52-week range 19.51
- YTD
- +51.97%
- 1 year
- +79.68%
Analyst view
Consensus: buy
Buy
Price target (mean) 20.00 +5.7% upside
Now 18.92
- Target (low)
- 14.00
- Target (mean)
- 20.00
- Target (high)
- 26.00
Ratings (0m) 12 7 buy · 4 hold · 1 sell
- Strong buy1
- Buy6
- Hold4
- Sell0
- Strong sell1
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.63802 | 0.61939 – 0.66081 | 0.67 | -4.8% | 3.79B | +0.8% | 10 |
| Next quarter | 0.5935 | 0.55686 – 0.64 | 0.57 | +4.1% | 3.72B | +0.3% | 10 |
| Current year | 2.51 | 2.46 – 2.55 | 2.35 | +6.9% | 14.78B | +3.4% | 11 |
| Next year | 2.70 | 2.59 – 2.84 | 2.51 | +7.5% | 15.22B | +3.0% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 26, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Oct 21, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 5, 2026 | UBS | Maintained | Buy | Buy |
| Sep 23, 2026 | Oppenheimer | Initiated | — | Outperform |
| Sep 16, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Sep 9, 2026 | Leerink Partners | Initiated | — | Outperform |
| Sep 8, 2026 | Argus Research | Maintained | Buy | Buy |
| May 19, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 8, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| May 8, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 28, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jan 16, 2026 | Argus Research | Upgrade | Hold | Buy |
| Dec 9, 2025 | Barclays | Initiated | — | Overweight |
| Oct 15, 2025 | Truist Securities | Initiated | — | Buy |
| Jun 6, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Mar 7, 2025 | Jefferies | Maintained | Buy | Buy |
| Mar 5, 2025 | Piper Sandler | Reiterated | Neutral | Neutral |
| Feb 28, 2025 | Barclays | Maintained | Underweight | Underweight |
| Feb 28, 2025 | B of A Securities | Maintained | Underperform | Underperform |
| Dec 6, 2024 | Piper Sandler | Reiterated | Neutral | Neutral |
| Nov 8, 2024 | Barclays | Maintained | Underweight | Underweight |
| Mar 28, 2024 | Piper Sandler | Reiterated | Neutral | Neutral |
| Nov 22, 2023 | Piper Sandler | Maintained | Neutral | Neutral |
| Oct 23, 2023 | B of A Securities | Downgrade | Neutral | Underperform |
| Jun 23, 2023 | Barclays | Downgrade | Equal-Weight | Underweight |
| Apr 25, 2023 | Barclays | Downgrade | Overweight | Equal-Weight |
| Apr 24, 2023 | Barclays | Downgrade | Overweight | Equal-Weight |
| Feb 28, 2023 | Barclays | Maintained | — | Overweight |
| Feb 17, 2023 | BMO Capital | Downgrade | Outperform | Market Perform |
